United States Pharmaceuticals

Auxilium Pharmaceuticals LLC (AUXL)

Track

Ticker: AUXL Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 5 Dec 2014
Value US$3,287,116.21 | Price 166.91 | Shares 35,673 (+26.8%)
Sale 5 Dec 2014
Value US$3,012,324.10 | Price 343.05 | Shares 67,653 (-48.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-12-08 2014-12-05 S Sale Lurker Nancy Non-Executive Director
35,673 +26.8%
166.91
US$3,287,116 		35,673 +26.8% 166.91 US$3,287,116
2014-12-08 2014-12-05 S Sale Lurker Nancy Non-Executive Director
67,653 -48.8%
343.05
US$3,012,324 		67,653 -48.8% 343.05 US$3,012,324
2014-12-08 2014-12-05 S Sale MCKEE WILLIAM Non-Executive Director
460 -39.4%
364.17
US$4,079,512 		460 -39.4% 364.17 US$4,079,512
2014-12-08 2014-12-05 S Sale ADAMS ADRIAN

CEO and President

Executive Director
40,000 -15.5%
33.97
US$1,358,704 		40,000 -15.5% 33.97 US$1,358,704
2014-12-08 2014-12-05 S Sale FRIEDMAN PAUL A Non-Executive Director
9,689 -48.3%
33.85
US$327,953 		9,689 -48.3% 33.85 US$327,953
2014-12-08 2014-12-04 S Sale FRIEDMAN PAUL A Non-Executive Director
20,000 -49.9%
33.67
US$673,452 		20,000 -49.9% 33.67 US$673,452
2014-12-04 2014-12-03 S Sale FETZER OLIVER Non-Executive Director
50,000 -72.3%
34.00
US$1,700,000 		50,000 -72.3% 34.00 US$1,700,000
2014-12-04 2014-12-02 S Sale CLASSON ROLF A Non-Executive Director
19,135 -65.7%
33.75
US$645,726 		19,135 -65.7% 33.75 US$645,726
2014-12-04 2014-12-02 S Sale CLASSON ROLF A Non-Executive Director
260,000 -89.9%
33.81
US$8,790,808 		260,000 -89.9% 33.81 US$8,790,808
2014-12-04 2014-12-02 S Sale FETZER OLIVER Non-Executive Director
50,000 -72.3%
34.03
US$1,701,635 		50,000 -72.3% 34.03 US$1,701,635
2014-11-26 2014-11-25 S Sale JOBES ELIZABETH VARKI

Chief Compliance Officer

Officer
23,750 -63.3%
34.03
US$808,310 		23,750 -63.3% 34.03 US$808,310
2014-11-26 2014-11-25 S Sale JOBES ELIZABETH VARKI

Chief Compliance Officer

Officer
4,052 -9.7%
34.05
US$137,964 		4,052 -9.7% 34.05 US$137,964
2014-11-26 2014-11-25 S Sale Tursi James Patrick

Chief Medical Officer

Officer
3,151 -9.0%
34.13
US$107,534 		3,151 -9.0% 34.13 US$107,534
2014-11-26 2014-11-25 S Sale Tursi James Patrick

Chief Medical Officer

Officer
10,562 -23.2%
34.12
US$360,394 		10,562 -23.2% 34.12 US$360,394
2014-11-24 2014-11-21 S Sale KOVEN ANDREW I

EVP, CAO, GC and Secretary

Officer
134,375 -77.6%
33.43
US$4,492,412 		134,375 -77.6% 33.43 US$4,492,412
2014-11-24 2014-11-21 S Sale KOVEN ANDREW I

EVP, CAO, GC and Secretary

Officer
5,308 -3.0%
33.44
US$177,518 		5,308 -3.0% 33.44 US$177,518
2014-11-24 2014-11-21 S Sale Armstrong Jennifer Lou

Senior Vice President, HR

Officer
69,412 -82.4%
33.50
US$2,325,031 		69,412 -82.4% 33.50 US$2,325,031
2014-11-24 2014-11-21 S Sale Armstrong Jennifer Lou

Senior Vice President, HR

Officer
6,391 -7.0%
33.50
US$214,075 		6,391 -7.0% 33.50 US$214,075
2014-11-24 2014-11-21 S Sale Tursi James Patrick

Chief Medical Officer

Officer
5,000 -12.5%
33.49
US$167,432 		5,000 -12.5% 33.49 US$167,432
2014-11-24 2014-11-21 S Sale Tursi James Patrick

Chief Medical Officer

Officer
3,648 -8.3%
33.45
US$122,011 		3,648 -8.3% 33.45 US$122,011
2014-11-24 2014-11-20 S Sale WILLS ALAN

EVP, Corporate Development

Officer
13,717 -30.9%
33.18
US$455,086 		13,717 -30.9% 33.18 US$455,086
2014-11-24 2014-11-20 S Sale WILLS ALAN

EVP, Corporate Development

Officer
142,875 -76.3%
33.18
US$4,740,207 		142,875 -76.3% 33.18 US$4,740,207
2014-11-24 2014-11-20 S Sale Glickman Mark A

EVP - Sales and Marketing

Officer
40,750 -59.3%
33.16
US$1,351,372 		40,750 -59.3% 33.16 US$1,351,372
2014-11-24 2014-11-20 S Sale Glickman Mark A

EVP - Sales and Marketing

Officer
7,202 -9.5%
33.18
US$238,963 		7,202 -9.5% 33.18 US$238,963
2014-11-24 2014-11-20 S Sale Tursi James Patrick

Chief Medical Officer

Officer
59,800 -57.8%
33.18
US$1,983,871 		59,800 -57.8% 33.18 US$1,983,871
2014-11-24 2014-11-20 S Sale Tursi James Patrick

Chief Medical Officer

Officer
6,200 -5.7%
32.94
US$204,253 		6,200 -5.7% 32.94 US$204,253
2014-03-17 2014-03-14 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
524 -8.3%
29.55
US$15,484 		524 -8.3% 29.55 US$15,484
2014-03-17 2014-03-14 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
883 -12.3%
29.55
US$26,093 		883 -12.3% 29.55 US$26,093
2014-03-17 2014-03-14 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
30,625 -57.4%
29.50
US$903,438 		30,625 -57.4% 29.50 US$903,438
2014-03-06 2014-03-05 S Sale CLASSON ROLF A Non-Executive Director
10,000 -30.4%
31.85
US$318,477 		10,000 -30.4% 31.85 US$318,477
2013-12-16 2013-12-13 PlS Planned sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
302 -6.9%
20.50
US$6,191 		302 -6.9% 20.50 US$6,191
2013-12-16 2013-12-13 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
4,300 -49.6%
20.50
US$88,150 		4,300 -49.6% 20.50 US$88,150
2013-12-12 2013-12-11 PlS Planned sale Fickenscher James E

Chief Financial Officer

Officer
71,067 -61.2%
20.37
US$1,447,450 		71,067 -61.2% 20.37 US$1,447,450
2013-05-22 2013-05-20 S Sale MCKEE WILLIAM Non-Executive Director
2,000 -20.0%
15.10
US$30,209 		2,000 -20.0% 15.10 US$30,209
2012-06-26 2012-06-25 PlS Planned sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
12,682 -73.9%
25.01
US$317,155 		12,682 -73.9% 25.01 US$317,155
2012-06-08 2012-06-06 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
5,700 -73.8%
22.55
US$128,536 		5,700 -73.8% 22.55 US$128,536
2012-06-08 2012-06-06 S Sale DEL TITO BENJAMIN J JR

EVP, Reg Affairs & Project Mgt

Officer
300 -3.7%
22.55
US$6,766 		300 -3.7% 22.55 US$6,766
2012-03-01 2012-02-28 B Purchase Brandt Peter C. Non-Executive Director
9,700 +3233.3%
20.10
US$194,970 		9,700 +3233.3% 20.10 US$194,970
2012-03-01 2012-02-28 B Purchase Brandt Peter C. Non-Executive Director
300 +inf%
20.09
US$6,028 		300 +inf% 20.09 US$6,028
2011-11-07 2011-11-03 B Purchase Fickenscher James E

Chief Financial Officer

Officer
1,610 +6.4%
15.54
US$25,024 		1,610 +6.4% 15.54 US$25,024
2011-10-11 2011-10-07 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -27.9%
14.23
US$75,046 		5,275 -27.9% 14.23 US$75,046
2011-08-03 2011-08-02 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
40,781 -0.7%
17.25
US$703,391 		40,781 -0.7% 17.25 US$703,391
2011-08-03 2011-08-02 S Sale 14159 capital (GP), LLC Large shareholder
1,001 -0.7%
17.25
US$17,265 		1,001 -0.7% 17.25 US$17,265
2011-08-03 2011-08-02 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
507 -0.7%
17.25
US$8,745 		507 -0.7% 17.25 US$8,745
2011-08-03 2011-08-02 S Sale Baker Biotech Capital (GP), LLC Large shareholder
6,361 -0.7%
17.25
US$109,715 		6,361 -0.7% 17.25 US$109,715
2011-08-03 2011-08-01 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
394,404 -6.7%
18.04
US$7,114,614 		394,404 -6.7% 18.04 US$7,114,614
2011-08-03 2011-08-01 S Sale 14159 capital (GP), LLC Large shareholder
9,678 -6.7%
18.04
US$174,580 		9,678 -6.7% 18.04 US$174,580
2011-08-03 2011-08-01 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
4,902 -6.7%
18.04
US$88,427 		4,902 -6.7% 18.04 US$88,427
2011-08-03 2011-08-01 S Sale Baker Biotech Capital (GP), LLC Large shareholder
61,519 -6.7%
18.04
US$1,109,735 		61,519 -6.7% 18.04 US$1,109,735
2011-08-03 2011-08-01 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
260,868 -4.3%
18.03
US$4,703,320 		260,868 -4.3% 18.03 US$4,703,320
2011-08-03 2011-08-01 S Sale 14159 capital (GP), LLC Large shareholder
6,400 -4.3%
18.03
US$115,389 		6,400 -4.3% 18.03 US$115,389
2011-08-03 2011-08-01 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
3,243 -4.3%
18.03
US$58,470 		3,243 -4.3% 18.03 US$58,470
2011-08-03 2011-08-01 S Sale Baker Biotech Capital (GP), LLC Large shareholder
40,690 -4.3%
18.03
US$733,620 		40,690 -4.3% 18.03 US$733,620
2011-07-12 2011-07-08 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -27.9%
20.30
US$107,101 		5,275 -27.9% 20.30 US$107,101
2011-03-31 2011-03-30 B Purchase 14159 capital (GP), LLC Large shareholder
3,911 +2.7%
21.98
US$85,963 		3,911 +2.7% 21.98 US$85,963
2011-03-31 2011-03-30 B Purchase Baker Bros. Capital (GP), LLC Large shareholder
309 +4.6%
21.98
US$6,792 		309 +4.6% 21.98 US$6,792
2011-03-31 2011-03-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
82,000 +1.4%
21.94
US$1,798,670 		82,000 +1.4% 21.94 US$1,798,670
2011-03-31 2011-03-29 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
250,000 +4.3%
22.00
US$5,499,400 		250,000 +4.3% 22.00 US$5,499,400
2011-03-10 2011-03-09 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
550,000 +10.5%
22.75
US$12,513,765 		550,000 +10.5% 22.75 US$12,513,765
2011-03-10 2011-03-09 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
115,000 +2.3%
23.44
US$2,695,060 		115,000 +2.3% 23.44 US$2,695,060
2011-03-10 2011-03-09 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
117,273 +2.3%
23.17
US$2,717,344 		117,273 +2.3% 23.17 US$2,717,344
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
58,388 +1.2%
22.81
US$1,331,976 		58,388 +1.2% 22.81 US$1,331,976
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
1,948 +0.0%
22.51
US$43,845 		1,948 +0.0% 22.51 US$43,845
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
48,657 +1.0%
22.86
US$1,112,299 		48,657 +1.0% 22.86 US$1,112,299
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
86,227 +1.8%
22.88
US$1,972,693 		86,227 +1.8% 22.88 US$1,972,693
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
1,612 +1.1%
22.81
US$36,774 		1,612 +1.1% 22.81 US$36,774
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
54 +0.0%
22.51
US$1,215 		54 +0.0% 22.51 US$1,215
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
1,343 +0.9%
22.86
US$30,701 		1,343 +0.9% 22.86 US$30,701
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
2,380 +1.7%
22.88
US$54,449 		2,380 +1.7% 22.88 US$54,449
2011-03-10 2011-03-08 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
10,996 +0.2%
23.05
US$253,503 		10,996 +0.2% 23.05 US$253,503
2011-03-10 2011-03-08 B Purchase 14159 capital (GP), LLC Large shareholder
304 +0.2%
23.05
US$7,008 		304 +0.2% 23.05 US$7,008
2011-03-09 2011-03-08 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -24.7%
23.03
US$121,502 		5,275 -24.7% 23.03 US$121,502
2011-03-09 2011-03-08 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,280 -24.7%
23.01
US$121,492 		5,280 -24.7% 23.01 US$121,492
2011-01-12 2011-01-10 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,275 -24.7%
23.27
US$122,723 		5,275 -24.7% 23.27 US$122,723
2011-01-12 2011-01-10 PlS Planned sale ANIDO ARMANDO

CEO & President

Executive Director
5,280 -24.7%
23.17
US$122,327 		5,280 -24.7% 23.17 US$122,327
Explore more

More insider trading research around Auxilium Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America